These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7658577)

  • 21. An alternative approach to myelodysplasia management: aggressive observation and prompt intervention.
    Teichman JM; Scherz HC; Kim KD; Cho DH; Packer MG; Kaplan GW
    J Urol; 1994 Aug; 152(2 Pt 2):807-11. PubMed ID: 8022020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of urodynamic evaluation in newborns with myelodysplasia.
    Bauer SB; Hallett M; Khoshbin S; Lebowitz RL; Winston KR; Gibson S; Colodny AH; Retik AB
    JAMA; 1984 Aug; 252(5):650-2. PubMed ID: 6737668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder].
    Luque Mialdea R; Martín-Crespo R; Hernández E; Sánchez O; Cañizo A; Fernández A; Aparicio C; Blanco T; Cebrían J
    Cir Pediatr; 2005 Jan; 18(1):3-7. PubMed ID: 15901100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation ileocystoplasty in children with myelodysplasia.
    Webber EM; Crofts PG; Pomeroy C; Coleman GU; Arnold WJ; Johnson HW
    Can J Surg; 1990 Apr; 33(2):135-8. PubMed ID: 2268813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The urological manifestations of hollow visceral myopathy in children.
    Ghavamian R; Wilcox DT; Duffy PG; Milla PJ
    J Urol; 1997 Sep; 158(3 Pt 2):1286-90. PubMed ID: 9258196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urological complications in children with myelodysplasia].
    Nikolaev VV; Braev AT
    Urologiia; 2000; (2):40-2. PubMed ID: 11186729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.
    Snow-Lisy DC; Yerkes EB; Cheng EY
    J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transverse myelitis in children: long-term urological outcomes.
    Tanaka ST; Stone AR; Kurzrock EA
    J Urol; 2006 May; 175(5):1865-8; discussion 1868. PubMed ID: 16600781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urological problems after surgical treatment of scoliosis in children with myelomeningocele.
    Boemers TM; Soorani-Lunsing IJ; de Jong TP; Pruijs HE
    J Urol; 1996 Mar; 155(3):1066-9. PubMed ID: 8583566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CKD and bladder problems in children.
    Penna FJ; Elder JS
    Adv Chronic Kidney Dis; 2011 Sep; 18(5):362-9. PubMed ID: 21896378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheterization: possible complications and their prevention and treatment.
    Igawa Y; Wyndaele JJ; Nishizawa O
    Int J Urol; 2008 Jun; 15(6):481-5. PubMed ID: 18430150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: a prospective study.
    Zhang Z; Liao L
    Spinal Cord; 2014 Jun; 52(6):468-71. PubMed ID: 24777160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of urodynamics and bladder management in predicting upper urinary tract complications in male spinal cord injury patients.
    Killorin W; Gray M; Bennett JK; Green BG
    Paraplegia; 1992 Jun; 30(6):437-41. PubMed ID: 1635794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological and functional factors predicting bladder deterioration after spinal cord injury.
    Yokoyama O; Hasegawa T; Ishiura Y; Ohkawa M; Sugiyama Y; Izumida S
    J Urol; 1996 Jan; 155(1):271-4. PubMed ID: 7490853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia.
    Medel R; Ruarte AC; Herrera M; Castera R; Podesta ML
    J Urol; 2002 Oct; 168(4 Pt 2):1849-52. PubMed ID: 12352374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
    Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
    J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bladder neck closure in children: a decade of followup.
    Landau EH; Gofrit ON; Pode D; Jurim O; Shenfeld OZ; Duvdevani M; Gross EM; Merguerian PA; Katz R
    J Urol; 2009 Oct; 182(4 Suppl):1797-801. PubMed ID: 19692069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplasia.
    McGuire EJ
    Semin Neurol; 1988; 8(2):145-9. PubMed ID: 3055120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.